Literature DB >> 1548081

Murine monoclonal antibodies to type Ib polysaccharide of group B streptococci bind to human milk oligosaccharides.

D G Pritchard1, B M Gray, M L Egan.   

Abstract

The chemical structures of the repeating units of the type Ib polysaccharide of group B streptococci and of the desialylated form of this antigen are almost identical to those of some oligosaccharides in human milk and certain fetal antigens. The structural similarities suggested that the molecules may be immunologically cross-reactive. Mouse monoclonal antibodies to the sialylated and nonsialylated forms of the type Ib polysaccharide were produced and tested for their ability to bind to immobilized human milk oligosaccharides. One antibody, SMB19, reacted specifically with the sialylated form of the type Ib polysaccharide and was also bound by an affinity column containing immobilized sialyllacto-N-tetraose a. The antibody was eluted from the affinity column with EDTA, since its binding to the antigen was calcium dependent. A second monoclonal antibody. SIbD2, bound specifically to the nonsialylated form of the type Ib polysaccharide and also to immobilized lacto-N-tetraose. The antibody was eluted from the affinity column at an acidic pH and retained immunologic activity. These results further extend our previous observations that certain antibodies raised against group B streptococci can also react with normal human glycoconjugates.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1548081      PMCID: PMC257035          DOI: 10.1128/iai.60.4.1598-1602.1992

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines.

Authors:  J F Kearney; A Radbruch; B Liesegang; K Rajewsky
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

2.  Structural similarity of the type-specific group B streptococcal polysaccharides and the carbohydrate units of tissue glycoproteins: evaluation of possible cross-reactivity.

Authors:  J Häyrinen; S Pelkonen; J Finne
Journal:  Vaccine       Date:  1989-06       Impact factor: 3.641

3.  Immunochemistry of purified polysaccharide type antigens of group B streptococcal types Ia, Ib, and Ic.

Authors:  H W Wilkinson
Journal:  Infect Immun       Date:  1975-04       Impact factor: 3.441

Review 4.  Philip Levine award lecture: blood group glycolipid antigens and their modifications as human cancer antigens.

Authors:  S Hakomori
Journal:  Am J Clin Pathol       Date:  1984-12       Impact factor: 2.493

5.  Immunogenicity of polysaccharides from type III, group B Streptococcus.

Authors:  C J Baker; M S Edwards; D L Kasper
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

Review 6.  Immunochemical characterization of the polysaccharide antigens of group B streptococci.

Authors:  D G Pritchard; M L Egan; B M Gray; H C Dillon
Journal:  Rev Infect Dis       Date:  1988 Jul-Aug

7.  Specificity of monoclonal antibodies against group B streptococcus type II and inhibition of their binding by human secretions.

Authors:  B M Gray; M L Egan; D G Pritchard
Journal:  Pediatr Res       Date:  1988-07       Impact factor: 3.756

8.  Quantitative determination in human sera of vaccine-induced antibody to type-specific polysaccharides of group B streptococci using an enzyme-linked immunosorbent assay.

Authors:  T K Eisenstein; B J De Cueninck; D Resavy; G D Shockman; R B Carey; R M Swenson
Journal:  J Infect Dis       Date:  1983-05       Impact factor: 5.226

9.  Immunochemical analysis of the types Ia and Ib group B streptococcal polysaccharides.

Authors:  R E Schifferle; H J Jennings; M R Wessels; E Katzenellenbogen; R Roy; D L Kasper
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Protection of mice from experimental infection with type III group B Streptococcus using monoclonal antibodies.

Authors:  M L Egan; D G Pritchard; H C Dillon; B M Gray
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  10 in total

1.  Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis.

Authors:  Rebekah E Wharton; Emily K Stefanov; R Glenn King; John F Kearney
Journal:  J Immunol       Date:  2015-03-27       Impact factor: 5.422

2.  Antibiofilm Activity of Lactobacillus plantarum 12 Exopolysaccharides against Shigella flexneri.

Authors:  Yinglong Song; Mengying Sun; Lu Feng; Xue Liang; Xing Song; Guangqing Mu; Yanfeng Tuo; Shujuan Jiang; Fang Qian
Journal:  Appl Environ Microbiol       Date:  2020-07-20       Impact factor: 4.792

Review 3.  Immunological Outcomes of Antibody Binding to Glycans Shared between Microorganisms and Mammals.

Authors:  Preeyam Patel; John F Kearney
Journal:  J Immunol       Date:  2016-12-01       Impact factor: 5.422

4.  Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha.

Authors:  C Larsson; M Stålhammar-Carlemalm; G Lindahl
Journal:  Infect Immun       Date:  1996-09       Impact factor: 3.441

5.  Human Milk Oligosaccharides Exhibit Antimicrobial and Antibiofilm Properties against Group B Streptococcus.

Authors:  Dorothy L Ackerman; Ryan S Doster; Jörn-Hendrik Weitkamp; David M Aronoff; Jennifer A Gaddy; Steven D Townsend
Journal:  ACS Infect Dis       Date:  2017-06-13       Impact factor: 5.084

6.  Antibodies generated against conserved antigens expressed by bacteria and allergen-bearing fungi suppress airway disease.

Authors:  Nicholas W Kin; Emily K Stefanov; Brian L P Dizon; John F Kearney
Journal:  J Immunol       Date:  2012-07-25       Impact factor: 5.422

7.  Protein rib: a novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections.

Authors:  M Stålhammar-Carlemalm; L Stenberg; G Lindahl
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

8.  Determinants of Group B streptococcal virulence potential amongst vaginal clinical isolates from pregnant women.

Authors:  Lindsey R Burcham; Brady L Spencer; Lauryn R Keeler; Donna L Runft; Kathryn A Patras; Melody N Neely; Kelly S Doran
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

Review 9.  Breast milk and Group B streptococcal infection: vector of transmission or vehicle for protection?

Authors:  Kirsty Le Doare; Beate Kampmann
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641

10.  SIgA, TGF-β1, IL-10, and TNFα in Colostrum Are Associated with Infant Group B Streptococcus Colonization.

Authors:  Kirsty Le Doare; Katie Bellis; Amadou Faal; Jessica Birt; Daniel Munblit; Holly Humphries; Stephen Taylor; Fiona Warburton; Paul T Heath; Beate Kampmann; Andrew Gorringe
Journal:  Front Immunol       Date:  2017-10-20       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.